D2-HG, a crucial metabolite produced by gliomas with IDH1 mutation, could potentially facilitate neuronal fusion by modifying neuronal molecular activity and triggering the mTOR signalling pathway. This evidence concerns the gene MTOR and central nervous system cancer.